PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-2.71%
Both yoy net incomes decline, with MRVL at -2425.26%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
-36.15%
Negative yoy D&A while MRVL is 31.88%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-88.89%
Negative yoy deferred tax while MRVL stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
No Data
No Data available this quarter, please select a different quarter.
-24.31%
Both reduce yoy usage, with MRVL at -286.85%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
No Data
No Data available this quarter, please select a different quarter.
194.12%
Some inventory rise while MRVL is negative at -705.77%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
No Data
No Data available this quarter, please select a different quarter.
-36.60%
Both reduce yoy usage, with MRVL at -232.24%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
1215.38%
Well above MRVL's 141.99%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-7.05%
Both yoy CFO lines are negative, with MRVL at -106.96%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-19.08%
Both yoy lines negative, with MRVL at -15.41%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-1300.00%
Both yoy lines negative, with MRVL at -81531.87%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
58.67%
Purchases well above MRVL's 100.00%. Michael Burry would see major cash outflow into securities vs. competitor’s approach, risking near-term FCF.
50.15%
We have some liquidation growth while MRVL is negative at -98.53%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
-100.00%
We reduce yoy other investing while MRVL is 0.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
259.57%
We have mild expansions while MRVL is negative at -283.94%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
No Data
No Data available this quarter, please select a different quarter.
-59.64%
Negative yoy issuance while MRVL is 341.84%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-33.29%
We cut yoy buybacks while MRVL is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.